线粒体损伤相关分子模式作为慢性阻塞性肺疾病生物标志物的研究进展

Research progress of mitochondrial damage-associated molecular patterns as biomarkers for chronic obstructive pulmonary disease

慢性阻塞性肺疾病(简称慢阻肺)发病率、致残率、死亡率高,经济负担沉重,是严重影响国人健康的重大疾病负担。围绕慢阻肺的诊断、评估与死亡风险预测,寻找可靠的生物标志物是目前的研究热点。线粒体损伤相关分子模式与慢阻肺关系密切,基于线粒体损伤相关分子模式有望寻找到慢阻肺的相关生物标志物,为慢阻肺的评估与治疗提供进一步的依据。本文就线粒体损伤相关分子模式在慢阻肺中的生物标志物功能研究进展进行综述。

Chronic obstructive pulmonary disease(COPD)has high incidence rate,disability rate,mortality rate,and heavy economic burden,and it is a major disease burden that seriously affects the health of Chinese population.Finding reliable biomarkers for the diagnosis,evaluation,and prediction of mortality risk in COPD is currently a research hotspot.The mitochondrial damage-associated molecular patterns are closely related to COPD.Based on mitochondrial damage-associated molecular patterns,it is expected to find relevant biomarkers for COPD,providing further basis for the evaluation and treatment of COPD.This article reviews the research progress of the biomarker role of mitochondrial damage-associated molecular patterns for COPD.